The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activated interferon-γ (IFN-γ) pathway associated with clinical benefit to programmed cell death protein-1 (PD-1)/PD ligand 1 (PD-L1)-based therapy in esophageal squamous cell carcinoma (ESCC).
 
Jhe-Cyuan Guo
Honoraria - Astellas Pharma; MSD; Ono Pharmaceutical
 
Min-Shu Hsieh
No Relationships to Disclose
 
Chia-Chi Lin
Consulting or Advisory Role - Boehringer Ingelheim; Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Lilly
 
Ta-Chen Huang
No Relationships to Disclose
 
Chun-Jung Chang
No Relationships to Disclose
 
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Ono Pharmaceutical
Consulting or Advisory Role - Lilly; MSD; Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Genentech (Inst); MSD (Inst); Ono Pharmaceutical (Inst)